Cidara Therapeutics Inc (NASDAQ: CDTX) stock closed at $17.45 on 11/21/24 after a major increase of 15.4%. Moreover, exceptionally high trading volume at 1523% of normal accompanied the advance. The stock has risen 25.5% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Cidara Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment